Toxoplasmic encephalitis in an HIV infected pregnant woman: successful outcome for both mother and child
AUTOR(ES)
Nogueira, Susie Andries, Guedes, Ana Lúcia, Machado, Elizabeth S., Matos, Juliana A., Costa, Tomás P., Cortes, Ely M., Lambert, John S.
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2002-08
RESUMO
This report describes a case of Toxoplasma encephalitis during pregnancy of an HIV infected woman who was severely immunosuppressed (CD4: 17 cells/mm3), had a high viral load (RNA PCR:230,000 copies/ml), was treated with sulfadiazine, pyrimethamine and folinic acid for toxoplasmosis and was being treated with highly potent antiretroviral drugs (AZT, 3TC and nelfinavir) for HIV infection. The newborn was born through an elective C-section, received six weeks of AZT according to the 076 protocol and was clinically normal at birth. Subsequently he had two RNA PCR negatives for HIV, seroreverted and had no clinical or laboratory evidence of congenital toxoplasmosis. Despite the concerns of the use of these combined therapies on the foetus during pregnancy, their efficacy illustrates that keeping the mother alive and in good health is an important strategy to protect the unborn child from acquiring these two infections.
Documentos Relacionados
- Ruptured Renal Artery Aneurysm in a Pregnant Woman: Case Report and Literature Review
- Hyponatremia, acute kidney injury, and mortality in HIV-related toxoplasmic encephalitis
- Schönlein-Henoch purpura during pregnancy with successful outcome for mother and newborn
- Gestantes soropositivas ao HIV: histórias sobre ser mulher e mãe
- Mother to child transmission of HIV in China: The numbers are small but rising, and two provinces have worrying HIV prevalence rates in pregnant women